The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 745K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

14 articles for S Tian


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Discovery of a 6-(pyridin-3-yl)benzo[d]thiazole template for optimization of hedgehog and PI3K/AKT/mTOR dual inhibitors.EBI
Soochow University
Synthesis and evaluation of dihydrofuro[2,3-b]pyridine derivatives as potent IRAK4 inhibitors.EBI
Soochow University
Structure-Activity Relationship Studies of Substituted 2-Phenyl-1,2,4-triazine-3,5(2H,4H)-dione Analogues: Development of Potent eEF2K Degraders against Triple-Negative Breast Cancer.EBI
Soochow University
Discovery of Selective P2YEBI
Soochow University
Engineering the Cyclization Loop of MCoTI-II Generates Targeted Cyclotides that Potently Inhibit Factor XIIa.EBI
The University of Queensland
Discovery and computational studies of 2-phenyl-benzoxazole acetamide derivatives as promising P2YEBI
Soochow University
Design, synthesis, and evaluation of potent RIPK1 inhibitors with in vivo anti-inflammatory activity.EBI
Soochow University
Ring closure strategy leads to potent RIPK3 inhibitors.EBI
Soochow University
Small Molecules Selectively Targeting Sigma-1 Receptor for the Treatment of Neurological Diseases.EBI
Soochow University
Structural optimization of aminopyrimidine-based CXCR4 antagonists.EBI
Soochow University
Development of novel NLRP3-XOD dual inhibitors for the treatment of gout.EBI
Soochow University
Structural optimization on a virtual screening hit of smoothened receptor.EBI
Soochow University
Iterative Optimization of the Cyclic Peptide SFTI-1 Yields Potent Inhibitors of Neutrophil Proteinase 3.EBI
The University of Queensland
Discovery of potent and novel smoothened antagonists via structure-based virtual screening and biological assays.EBI
Soochow University